Jason Wild first joined the board as Chairman of TerrAscend after leading a private placement into the company in 2017. Having built a deep knowledge base and network in the cannabis industry over the years, Mr. Wild brings strategic value as an investor and partner. He works collaboratively with the board and management team to help guide the company’s strategy and source M&A opportunities with his extensive network.

In addition to his role with TerrAscend, Mr. Wild is the President & Chief Investment Officer of JW Asset Management, an SEC-registered investment adviser with more than $500 million in assets under management. Starting his first fund in 1998 with under $100,000 in assets, Jason achieved early success by leveraging his background as a pharmacist finding undervalued, specialty pharmaceutical companies and focusing on long-term price appreciation. After building a strong track record as a stock picker, Jason expanded his investment universe and applied his experience and extensive healthcare network to private equity opportunities. He has since established himself as a highly respected investor and sought-after partner for both public and private companies. His Firm’s 20+ year audited track record is a testament to consistently sourcing quality deal flow, identifying exceptional investment opportunities, and adding significant value as both a portfolio manager and trusted business partner.